Sebastiano Nazzani

5PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 25, 2026
Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

|Apr 09, 2026
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors management.

Sebastiano Nazzani, Carlo Silvani, Cesare Saitta

|Sep 01, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Luca Antonelli, Davide Ardizzone, Isamu Tachibana

|Aug 02, 2022
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.

Nicola Nicolai, Sebastiano Nazzani, Antonio Tesone

|Oct 10, 2018
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.

Sebastiano Nazzani, Felix Preisser, Elio Mazzone

Pageof 1

Frequent Collaborators

2 joint publications

Giuseppe Procopio

2 joint publications

Barbara Avuzzi

1 joint publications

Davide Biasoni

1 joint publications

Isamu Tachibana